Premium
Immunological Adjuvant Effect of Ginsenoside Rh 4 from the Roots of Panax notoginseng on Specific Antibody and Cellular Response to Ovalbumin in Mice
Author(s) -
Yang ZhiGang,
Ye YiPing,
Sun HongXiang
Publication year - 2007
Publication title -
chemistry and biodiversity
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.427
H-Index - 70
eISSN - 1612-1880
pISSN - 1612-1872
DOI - 10.1002/cbdv.200790028
Subject(s) - ovalbumin , panax notoginseng , adjuvant , chemistry , concanavalin a , saponin , splenocyte , antibody , ginsenoside , lipopolysaccharide , haemolysis , pharmacology , antibody response , andrology , immunology , immune system , microbiology and biotechnology , biochemistry , ginseng , biology , medicine , in vitro , alternative medicine , pathology
Ginsenoside Rh 4 ( 1 ), a saponin isolated from the roots of Panax notoginseng ( Burk .) F. H. Chen , was evaluated for its haemolytic activity and adjuvant potential on specific antibody and cellular response to ovalbumin (OVA) in mice. Compound 1 showed a slight haemolytic effect, its concentration inducing 50% of the maximum haemolysis ( HD 50 value) being 407±12 μg/ml using a 0.5% suspension of red blood cells. Compound 1 significantly increased the concanavalin A (Con A)‐, lipopolysaccharide (LPS)‐, and OVA‐induced splenocyte proliferation in OVA‐immunized mice especially at a dose of 25 μg ( P <0.05, P <0.01, or P <0.001). The OVA‐specific serum IgG, IgG1, and IgG2b antibody levels were also significantly enhanced by 1 at a dose of 25 μg compared to the OVA control group ( P <0.05 or P <0.01). Moreover, the enhancing effect of 1 on the OVA‐specific IgG2b antibody responses to OVA in mice was more significant than that of Alum (Al(OH) 3 gel; P <0.01). These results suggest that 1 could be safely used as adjuvant with low or non‐haemolytic effect.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom